Evaluating
the
feasibility
of
measures
of
motor
threshold
and
cortical
silent
period
as
predictors
of
outcome
after
temporal
lobe
epilepsy
surgery
O
¨ mer
Karadas¸
a,
H.
I˙lker
Ipekdal
b,*
,
Ersin
Erdog˘an
c,
Zeki
Go¨kc¸il
a,
Zeki
Odabas¸
i
aaGu¨lhaneMilitaryMedicalAcademy,DepertmentofNeurology,Ankara,Turkey b
NearEastUniversityHospital,DepartmentofNeurology,NearEastStreet,Nycosia,Cyprus
c
UfukUniversityFacultyofMedicine,DepartmentofNeurosurgery,Ankara,Turkey
1. Introduction
Epileptic disorders are the clinical result of excitatory and inhibitorysystemimbalancewithinthecentralnervoussystem.1 Surgicalremovaloftheepilepticfocusiswidelyacceptedasan effectivetherapyforselectedpatientswithmedicallyrefractory epilepsy; however, there is no consensus regarding accurate predictorsofsurgicaloutcomedue totheuseofheterogeneous studygroups,differencesinsurgicalproceduresanddurationof follow-up,andvaryingdefinitionsofsurgicalsuccessandfailure. Theprimarymeasureoftheoutcomeofepilepsysurgery(ES)is the end of seizures, and secondary outcome measures are the frequencyandseverityofseizures,qualityoflife,levelofdisability, and mortality.2–5 Transcranial magnetic stimulation (TMS) has
beenusedtonon-invasivelyandalmostpainlesslyinvestigatethe human cerebral cortex. The motor threshold (MT) and cortical silentperiod(CSP),and intracorticalinhibitionand intracortical facilitationhavebeenusedtoevaluatemotorcortexexcitability.6 Corticalexcitabilityislikelytochangeaftersurgicalremovalof theepilepticfocus;7,8therefore,TMSparametersmaybeusefulfor
predictingtheoutcomeofES.Thepresentstudyaimedtoassess the value of the MT and CSP as predictors of the outcome of temporallobeepilepsysurgery(TLES).
2. Materialsandmethods
Thestudyincluded10patients(8femaleand2male)aged25–39 years (mean age:30.7 years) withdrug-resistant temporal lobe epilepsy(Table1).Thepatientsunderwentpre-surgicalmonitoring at Gu¨lhaneMilitary MedicalHospital,Department ofNeurology, EpilepsyMonitoringUnit,Ankara,TurkeybetweenJanuary2005and May2009. Epilepticfociwereidentified andsurgicaltechniques werechosenbasedontheresultsofvideo-electroencephalography
Seizure20(2011)775–778
A R T I C L E I N F O Articlehistory:
Received25August2010
Receivedinrevisedform17July2011 Accepted18July2011
Keywords:
Temporallobeepilepsysurgery Corticalsilentperiod Motorthreshold Corticalexcitability
A B S T R A C T
Introduction: AlthoughitiswellknownthatESalterscorticalexcitability,littleisknownaboutthe
relationshipbetweenESoutcomeandcorticalexcitability.Transcranialmagneticstimulationhasbeen
successfullyusedtoevaluatecorticalexcitabilityinepilepsypatients.Thepresentstudyaimedtoassess
thevalueofthemotorthreshold(MT)andcorticalsilentperiod(CSP)aspredictorsoftheoutcomeof
temporallobeepilepsysurgery(TLES).
Materialsandmethods:Epilepticfociintheepilepsypatientswereidentifiedvia
video-electroencepha-lography (v-EEG) monitoring, brain magnetic resonance imaging (MRI), single-photon emission
computed tomography (SPECT), and positron emission tomography (PET), and neurophysiological
testing.MT,CSP-150,andCSP-maxweremeasuredin10epilepsypatientsonboththeipsilateraland
contralateralsideoftheepilepticfocus1weekbeforeand3monthsafterTLES.Pre-andpost-operative
MTandCSPmeasurementswerecompared,andtheresultswereinterpreted basedontheclinical
outcomeofTLES.
Results:Meanfollow-upperiodwas28.8months.Inall,8patientswereseizure-freepostTLES,whereas
in2patientsseizurespersisted.Nosignificantdifferenceswereobservedinipsilateralorcontralateral
hemisphereMTmeasurementsbeforeandaftersurgery.BothCSP-150andCSP-maxvaluesinthe
non-focalhemispheresdecreasedinthe8patientsthatwereseizure-freepostTLES,whereasnodifferences
wereobservedinthe2patientswithseizuresthatpersistedpostTLES.
Conclusions: Thepresentfindingsindicatethatmonitoringpre-andpost-TLESCSPchangesmaybe
predictiveoftheearlyclinicaloutcomeofTLES.
ß 2011BritishEpilepsyAssociation.PublishedbyElsevierLtd.Allrightsreserved.
*Correspondingauthor.Tel.:+905068433122/3123044493; fax:+903123045900.
E-mailaddress:iipekdal@yahoo.com(H.&.Ipekdal).
ContentslistsavailableatScienceDirect
Seizure
j o urn a lhom e pa g e :ww w . e l se v i e r. c om / l oca t e / y se i z
1059-1311/$–seefrontmatterß2011BritishEpilepsyAssociation.PublishedbyElsevierLtd.Allrightsreserved. doi:10.1016/j.seizure.2011.07.009
(v-EEG) monitoring, brain magnetic resonance imaging (MRI), single-photonemissioncomputedtomography(SPECT),and posi-tronemissiontomography(PET),andneurophysiologicaltesting.All ofthepatientsprovidedwritteninformedconsenttoundergoTLES, andTMStestingbeforeandafterTLES.TheGu¨lhaneMilitaryMedical HospitalEthicsCommitteeapprovedthestudyprotocol.
Patients1and5underwentanteromedialtemporallobectomy (AMTL), and the others underwent AMTL and amygdalohippo-campectomy(AHCT).DuringAMTL,3.5cmofthetemporalpole (fromthetemporaltip)wasremoved,includinghalfofthesuperior temporalgyrus,andthemiddleandinferiortemporalgyri.During AHCT,theamygdala,anteriorpartofthetailofthehippocampus, and the entire head and body of the hippocampus and parahippocampal gyrus were surgically removed. Following surgery,thepatients’antiepilepticdrug(AED)regimensremained unchanged.Additionally,pre-surgicalandpost-surgicalAEDblood levels were identical and within therapeutic ranges. Patient characteristicsareshowninTable1.
TMS testing was performed 7 days prior to surgery by a neurologistblindedtothelocationofeachpatient’sepilepticfocus. TMS testing was repeated 3 months post surgery by another neurologistblindedtothepre-surgerymeasurements.TMStesting inpatients 4and7–whoseseizurespersistedpostTLES–was performed at least 3 days after they had seizures. TMS was performedwhilethepatientswereinaseatedposition,usinga 9-cmdiametercircularcoil(DantecMC125)capableofgeneratinga peak magneticfield of1.0T.Responses oftheabductor pollicis brevis (APB) muscles were recorded bilaterally with a Dantec EvolutionEMGapparatus,usingAg–Clsurfaceelectrodes.Thecoil wasplacedoverthescalpprojectingthemotorcortexareaabout 7cm lateralof thevertex.Thepositionofthecoilwaschanged slightly and the stimulus was administered until the optimal positionforAPBmuscleresponsewasdetermined.8–10
2.1. MTmeasurement
MTwasdefinedasthelowestintensitystimulusrequiredto elicitanMEP5010-
m
VinamplitudefromtherestingAPBmuscle, with5successfultrialsoutof10.Initialstimulusintensitywas30% ofthemaximumstimulusintensityandwasincreasedby1–5%until we obtained the MT. MT was measured for both APB muscles independently.2.2. CSPmeasurement
CSP-150andCSP-maxmeasurementswereobtainedforeach patient.Duringtheprocedurepatientswererequestedtocontract theirAPBmusclesusing50%oftheirmaximumcontractionforce. ForCSP-150measurementthestimulusintensitywasadjustedto 1.5-foldthatoftheMTmeasurementforthesameAPBmuscleand wasadministeredfromthecontralateralsideofthescalpduring contractionoftheABPmuscle.CSP-150wasdefinedasthemean valueof5measurementsandCSP-maxwasdefinedasthemean value of 5 CSP measurements obtained with the maximum stimulusintensity.9–12
Seizure-free wasdefinedas no seizureduringthefollow-up period.Pre-and post-surgical MTand CSPmeasurementswere compared, in terms of the side of epileptic focus and the contralateral side. Statistical evaluation of the data acquired beforeandaftersurgerywasperformedusingthepairedttest. 3. Results
None of thepatients experiencedcomplications during TMS testing. Mean pre-surgical MT (as a percentage of maximum stimulus intensity) was 52.72.6% on the ipsilateral side and
Table 1 Patient characteris tics. Patient Age (years) Gender Fam ily histo ry Handedness Duration of disease (years) Seizure type(s ) before surgery
Seizures during sleep
Etiology
Seizure frequency before
surgery Surgical procedure AEDs before and after surgery Seizure frequency after surgery
Post-surgical follow-up period
(months) 1 3 4 Fem ale No Ambidextrous 33 CPS Yes Left MTS 2–3/month Left AMTL VPA, OXC, LEV No seizure 15 2 2 5 Fem ale No Right 19 CPS, SGTCS No Right MTS 1–2/month Right AMTL + AHCT CBZ, LEV No seizure 51 3 3 8 Fem ale No Right 14 CPS No Right MTS 1–2/week Right AMTL + AHCT CBZ, TP, LEV No seizure 11 4 3 9 Fem ale No Right 38 CPS, SGTCS Yes Right MTS 1–2/week Right AMTL + AHCT VPA, CBZ, LEV 1–2/w eek 24 5 2 8 Fem ale Aun t Left 11 CPS, SGTCS No Right MTS 1–2/month Right AMTL VPA, CBZ No seizure 53 6 2 8 Fem ale Sister Right 26 CPS, SGTCS Yes Left MTS 1–2/month Left AMTL + AHCT VPA, CBZ, LEV No seizure 57 7 2 9 Fem ale Fathe r and brother Right 17 CPS, SGTCS No Right MTS 2–3/month Right AMTL + AHCT CBZ, LEV, TP 2–3/month 23 8 2 9 M ale No Right 27 CPS, SGTCS No Left MTS 1–2/month Left AMTL + AHCT CBZ, TP No seizure 12 9 2 6 M ale No Right 13 CPS, SGTCS Yes Right MTS 5–6/month Right AMTL + AHCT CBZ, LEV No seizure 27 10 31 Fem ale Fathe r Right 25 CPS No Left MTS 1–2/week Left AMTL + AHCT VPA, CBZ No seizure 15 CPS: complex partial seizure; SGTCS: secondary generalized tonic–clonic seizure; MTS: mesial temporal sclerosis; AMTL: anteromedial temporal lo bectomy; AHCT: amygdalohippocampectomy; VPA: valproic acid; CBZ: carbamazepine; OXC: oxcarbazepine; LEV: levetiracetam; TP: topiramate.
O¨.Karadas¸etal./Seizure20(2011)775–778 776
53.31.7% on the contralateral side. Post-surgical MT was 53.42.9%ontheipsilateralsideand51.71.6%onthe
contralat-eralside(Table2).Pre-andpost-surgicalMTvaluesfortheipsilateral
andcontralateralsidesdiddiffersignificantly(P=0.42andP=0.04, respectively).
Pre-surgicalmeanCSP-150was145.711.3msonthe ipsilat-eralsideand146.310.1msonthecontralateralside.Post-surgical mean CSP-150 was 142.312.2ms on the ipsilateral side and 137.212.2msonthecontralateralside.Differenceswerenotnoted betweenpre-andpost-surgicalCSP-150valuesontheipsilateralside, but post-surgical mean CSP-150 on the contralateral side was significantly shorter than the pre-surgical value (P=0.19 and P=0.008,respectively).
Pre-surgical mean CSP-max was 153.711.2ms on the ipsilateralsideand157.212.1msonthecontralateralside. Post-surgicalmeanCSP-maxwas147.611.8msontheipsilateralside and142.212.2ms onthe contralateral side.Post-surgical mean CSP-maxontheipsilateralandcontralateralsideswassignificantly shorter than the pre-surgical values (P=0.011 and P=0.007, respectively).Additionally,meanCSP-maxwassignificantlylonger than mean CSP-150 on the contralateral side post-surgically (P=0.005).CSPresultsaresummarizedinTable3.
Postsurgery,thepatientscontinuedtoreceivethesameAED treatmenttheyreceivedpre-surgery.Meandurationoffollow-up was28.8months(range:11–57months);8patientswere seizure-free post TLES,whereas patients 4 and 7 had no reduction in seizurefrequencyorseverity(Table1).
4. Discussion
Thepresentstudy’sresultsindicatethatthepost-TLESCSP–not MT–wasshorterinthe8patientsthatwereseizure-freepostTLES. Patients 4 and 7 had no improvement in seizure frequency or seizureseveritypostsurgeryandtheirMTandCSPvaluesbefore andafterESweresimilar.
Epilepticdisordersarecharacterizedbyheterogeneous patho-physiological processes that lead to alteration in the balance betweenexcitatoryandinhibitoryinfluencesatthecorticallevel.It hasbeenproventhatAEDscanaltertheMTandCSPinepilepsy patients by reorganizing cortical excitability. The MThas been reportedtobelow,normal,andhighinepilepsypatients.Many studies have suggested that the discrepancy between MT measurementsmightbeduetothefactthattheMTisadynamic phenomenonthatvariesaccordingtoseizuretype.Althoughthe resultsofstudiesontheeffectsofAEDsontheMTareinconsistent, CSP duration has been reported to decrease following AED treatment,13,14 which maybe a result of theclose relationship
between theCSP and theGABAergicsystem.GABA-Areceptors mediateshort-durationinhibitorypostsynapticpotentials(IPSPs), whereas GABA-B receptors mediate long-duration IPSPs. Some researchersproposethatCSPdurationisanindicatorofGABA-B receptor-mediatedmotorcorticalinhibition.14–16
The epileptic focus can affect excitatory and inhibitory mechanismsonboththeipsilateralandcontralateralsides.Several studiesonfocalepilepsysupportthenotionthattheepilepticfocus hasbilateraleffectsthatmaybestrongeronthecontralateralside. Themechanismsunderlyingthesechangesremaintobe elucidat-ed; a low local inhibitory level caused by the presence of an excitatory epileptic focus is 1 hypothesis.9,17,18 As with AED
treatment,surgicalexcisionoftheepilepticfocuscanreorganize corticalexcitability.
La¨ppchen et al. were the first to study changes in cortical excitabilityfollowingsuccessfulES.9TheyobservedthattheMTon
the ipsilateral side was significantly higher than that on the contralateralsidefollowingsuccessfulES.Inthepresentstudyno differencesinMTonboththeipsilateralandcontralateralsides wereobservedbefore andafterTLES.Suchcontradictoryresults may be related to the surgical procedures employed or the dynamic nature ofthe MT.On theotherhand,La¨ppchen et al. reportedthattheCSPwasprolongedontheipsilateralsidebefore ES,whichindicatesthattheepilepticfocushasasignificantaffect on the contralateral hemisphere, and that the changes on the ipsilateral sidewerecomparatively minor.TheCSP was signifi-cantly shorter on the contralateral side after successful ES, indicating that there wasa reductionin intracorticalinhibition onthecontralateralsidefollowingES.9
InthepresentstudyCSP-150andCSP-maxonthecontralateral sidewereshorterinthe8patientsthatwereseizure-freeduring post-surgical follow-up; however, although v-EEG monitoring, brain MRI, SPECT, and PET, and neurophysiological testing facilitated identification of the epileptic foci, TLES failed in 2 patients (patients4and7)thathadno improvementinseizure frequencyorseverityduringfollow-up.Surprisingly,althoughthe epilepticfocus in patient4 was locatedon theleft side before surgery, v-EEG monitoring performed 14 months post surgery showedthattheepilepticfocuswasontheleftside.Furthermore, MT,CSP-150,andCSP-maxmeasurementsontheipsilateraland contralateralsidespre-andpostsurgerydidnotdifferinpatients4 and7.Additionally,asbothCSP-150andCSP-maxmeasurements onthecontralateralsidewerethesame,werecommendusing CSP-150insteadofCSP-maxinordertoavoidthepotentialside-effects ofTMStesting.
ResearcheshaveshownthatTLEScanresultincompleteseizure remission rates of up to80% in patients withmesial temporal sclerosisandunilateralseizures.Theseizure-freerateafterTLESin patients withextratemporal non-lesional epilepsy is 30–40%.19
Thedurationofpost-surgicalfollow-upisimportantin determin-ingseizure-freeandqualityoflifeoutcomesfollowingTLES.Ithas beensuggestedthatoutcomeat1yearpostTLESisagoodpredictor oflong-termoutcome.20–24
Themainlimitationsofthepresentstudyarethesmallnumber of patients and the lack of final diagnoses supported by histopathology.Additionally,thepresentresultsmayhavebeen affectedbythedifferentsurgicalproceduresemployed;however, thesurgicalprocedureswerechosenbasedonthetestsusedto evaluatethepatientsandidentifytheepilepticfoci,andtheclinical experienceoftheneurosurgeons.Largerwell-designedstudiesare needed in order to obtain more definitive results. There is a possibilitythatTMStestinginthe2patientsthatstillhadseizures post surgery may have contributed to the persistence of the seizures; however, we think it unlikely as we performed TMS testing5daysafterseizureinpatient4and9daysafterseizurein patient7.
Table2
Pre-andpost-surgicalMTvalues. MeanMT(%)
Ipsilateralside Contralateralside
Pre-surgical 52.72.6 53.31.7
Post-surgical 53.42.9 51.71.6
Table3
Pre-andpost-surgicalCSPvalues.
CSP-150(ms) CSP-max(ms) Ipsilateral side Contralateral side Ipsilateral side Contralateral side Pre-surgical 145.711.3 146.310.1 153.711.2 157.212.1 Post-surgical 142.312.2 137.212.2 147.611.8 142.212.2
Althoughthedurationofpost-surgicalfollow-upisessentialfor theassessmentofseizure-freeoutcomeofTLES,thepresentresults indicatethatevaluationofthedifferencebetweenpre-and post-TLES CSP may be predictive of clinical outcome. Although the presentstudygroupwassmall,thefindingsinpatients 4and7 indicatethatunalteredCSPvaluesfollowingTLESmayberelatedto apooroutcome;however,theresultsofthissmall-scalefeasibility studyindicatethatCSPmaybeausefulpredictoroflonger-term post surgical outcome and that larger prospective studies are warranted.
References
1.AvoliM,LouvelJ,PumainR,Ko¨hlingR.Cellularandmolecularmechanismsof epilepsyinthehumanbrain.ProgNeurobiol2005;77(3):166–200.
2.ElsharkawyAE,MayT,ThorbeckeR,Koch-StoeckerS,VillagranA,UrakL,etal. Long-termoutcomeanddeterminantsofqualityoflifeaftertemporallobe epilepsysurgeryinadults.EpilepsyRes2009;86(2–3):191–9.[Epub24.07.09]. 3.ElsharkawyAE,AlabbasiAH,PannekH,OppelF,SchulzR,HoppeM,etal. Long-termoutcomeaftertemporallobeepilepsysurgeryin434consecutiveadult patients.JNeurosurg2009;110(6):1135–46.
4.MeadorKJ.Predictorsoftemporallobeepilepsysurgeryoutcomes.EpilepsyCurr 2003;3(4):125–6.
5.UnnwongseK,WehnerT,Foldvary-SchaeferN.Selectingpatientsforepilepsy surgery.CurrNeurolNeurosciRep2010;10(4):299–307.
6.TassinariCA, Cincotta M,Zaccara G, MichelucciR. Transcranial magnetic stimulationandepilepsy.ClinNeurophysiol2003;114(5):777–98.
7.La¨ppchenCH,FeilB,FauserS,GlockerFX,Schulze-BonhageA.Changesin interhemisphericinhibitionfollowingsuccessfulepilepsysurgery:aTMSstudy. JNeurol2011;258(January(1)):68–73.[Epub31.07.10].
8.La¨ppchenCH,FeilB, FauserS, WuwerY, GlockerFX,Schulze-Bonhage A. Changesinintracorticalexcitabilityaftersuccessfulepilepsysurgery.Epilepsy Res2008;79(1):55–62.
9.KenechtS,SommerJ,DeppeM,Steinstra¨terO.Scalppositionandefficacyof transcranialmagneticstimulation.ClinNeurophysiol2005;116:1988–93. 10.TatarogluC,OzkiziltanS,BaklanB.Motorcorticalthresholdsandcorticalsilent
periodsinepilepsy.Seizure2004;13(7):481–5.
11.MacdonellRA,CuratoloJM,BerkovicSF.Transcranialmagneticstimulationand epilepsy.JClinNeurophysiol2002;19(4):294–306.
12.InghilleriM,BerardelliA,CruccuG,Manfredi M.Silent periodevokedby transcranialstimulationofthehumancortexandcervicomedullaryjunction. JPhysiol1993;466:521–34.
13.BadawyRA,MacdonellRA,BerkovicSF,NewtonMR,JacksonGD.Predicting seizurecontrol:corticalexcitabilityandantiepilepticmedication.AnnNeurol 2010;67(1):64–73.
14.ZiemannU,SteinhoffBJ,TergauF,PaulusW.Transcranialmagneticstimulation: itscurrentroleinepilepsyresearch.EpilepsyRes1998;30(1):11–30. 15.McDonnellMN,OrekhovY, ZiemannU.TheroleofGABA(B) receptorsin
intracortical inhibition in the human motor cortex. Exp Brain Res 2006;173(1):86–93.
16.vandenWildenbergWP,BurleB,VidalF,vanderMolenMW,RidderinkhofKR, HasbroucqT.Mechanismsanddynamicsofcorticalmotorinhibitioninthe stop-signalparadigm:aTMSstudy.JCognNeurosci2010;22(2):225–39. 17.CincottaM,BorgheresiA,LoriS,FabbriM,ZaccaraG.Interictalinhibitory
mechanismsinpatientswithcryptogenicmotorcortexepilepsy:astudyof thesilentperiodfollowingtranscranialmagneticstimulation. Electroencepha-logrClinNeurophysiol1998;107(1):1–7.
18.HamerHM,ReisJ,MuellerHH,KnakeS,OverhofM,OertelWH,etal.Motor cortexexcitabilityinfocalepilepsiesnotincludingtheprimarymotorarea:a TMSstudy.Brain2005;128(Pt4):811–8.
19.SelwaLM,SchmidtSL,MalowBA,BeydounA.Long-termoutcomeof nonsurgi-calcandidateswithmedicallyrefractorylocalization-relatedepilepsy.Epilepsia 2003;44(12):1568–72.
20.McIntoshAM,KalninsRM,MitchellLA,FabinyiGC,BriellmannRS,BerkovicSF. Temporallobectomy:long-termseizureoutcome,laterecurrenceandrisksfor seizurerecurrence.Brain2004;127(Pt9):2018–30.
21.WiebeS,BlumeWT,GirvinJP,EliasziwM.Arandomized,controlledtrialof surgeryfortemporal-lobeepilepsy.NEnglJMed2001;345(5):311–8. 22.Te´llez-ZentenoJF,DharR,WiebeS.Long-termseizureoutcomesfollowing
epilepsysurgery:asystematicreviewandmeta-analysis.Brain2005;128(Pt 5):1188–98.
23.KelemenA,BarsiP,ErossL,VajdaJ,Czirja´kS,Borbe´lyC,etal.Long-term outcomeaftertemporallobesurgery–predictionoflateworseningofseizure control.Seizure2006;15(1):49–55.
24.Cohen-GadolAA,WilhelmiBG,CollignonF,WhiteJB,BrittonJW,CambierDM, etal.Long-termoutcomeofepilepsysurgeryamong399patientswith non-lesional seizurefociincluding mesialtemporallobesclerosis. JNeurosurg 2006;104(4):513–24.
O¨.Karadas¸etal./Seizure20(2011)775–778 778